Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child–Pugh grade B patients with locally advanced hepatocellular carcinoma

por Li, Jian-Xu, Zhang, Rui-Jun, Qiu, Mo-Qin, Yan, Liu-Ying, He, Mei-Ling, Long, Mei-Ying, Zhong, Jian-Hong, Lu, Hai-Yan, Zhou, Hong-Mei, Xiang, Bang-De, Liang, Shi-Xiong
Publicado 2023

Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study

por Li, Jian-Xu, Deng, Wen-Xiang, Huang, Shi-Ting, Lin, Xiao-Feng, Long, Mei-Ying, Zhang, Jie, Su, Ting-Shi, Li, Li-Qing, Pang, Ya-Dan, Liang, Chun-Feng, Zhou, Hong-Mei, Lu, Hai-Yan, Liang, Shi-Xiong, Xiang, Bang-De
Publicado 2022

Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma

por Zhang, Rui-Jun, Zhou, Hong-Mei, Lu, Hai-Yan, Yu, Hong-Ping, Tang, Wei-Zhong, Qiu, Mo-Qin, Yan, Liu-Ying, Long, Mei-Ying, Su, Ting-Shi, Xiang, Bang-De, He, Mei-Ling, Wang, Xiao-Ting, Liang, Shi-Xiong, Li, Jian-Xu
Publicado 2023

Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy

por Li, Jian-Xu, He, Mei-Ling, Qiu, Mo-Qin, Yan, Liu-Ying, Long, Mei-Ying, Zhong, Jian-Hong, Zhang, Rui-Jun, Liang, Chun-Feng, Pang, Ya-Dan, He, Jun-Kun, Chen, Qian-Qian, Weng, Jin-Xia, Liang, Shi-Xiong, Xiang, Bang-De
Publicado 2022